openPR Logo
Press release

Immunoglobulin Market With High Potential Growth, Expected Reach A Valuation Of $17,501 Million by 2025

02-19-2019 03:18 PM CET | Health & Medicine

Press release from: Allied Market Research

Immunoglobulin Market Size

Immunoglobulin Market Size

The major factors that fuel the Immunoglobulin Market growth during the forecast period include increase in geriatric population & number of hemophilic patients, improved immunoglobulin production owing to the emergence of advanced technologies, and enhanced purification techniques (with better plasma yield). Furthermore, surge in prevalence diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia & others are expected to boost the market growth. However, stringent government regulations toward immunoglobulin products and high risk of side effects owing to the use of immunoglobulin are expected to hamper the growth of the market.

Global Immunoglobulin Market was valued at $8,374 million in 2016, and is projected to reach $13,619 million by 2023, registering a CAGR of 7.3% from 2017 to 2023.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2586

The key companies profiled in the report include

• Baxter international Inc.,
• CSL Ltd,
• Grifols S.A,
• Octapharma AG,
• Kedrion Biopharma Inc.,
• LFB group,
• Biotest AG,
• China Biologics Products Inc.,
• BDI Pharma Inc., and
• Bayer Healthcare.

In 2016, North America accounted for maximum contribution to the total revenue generated, followed by Asia-Pacific. The major factors responsible for the growth of immunoglobulin market in these regions are the high adoption rate in developed and populous countries such as Japan and U.S. and the presence of large plasma production facilities.

Immunoglobulin is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. Immunoglobulin is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology.

Prevalence of various antibody deficiency disorders such as common variable immune deficiency (CVID), specific antibody deficiency, and hypogammaglobulinemia, increase in immunoglobulin indications, improved production & purification processes, growth in awareness towards antibody deficiency, and rare immune disorders among patient population drive the growth of the Immunoglobulin market. However, high costs associated with the immunoglobulin treatment; shortage of immunoglobulin; and side effects of immunoglobulin treatment such as headache, migraine, fever, nausea or vomiting, and cough hinder the market growth. Immunoglobulin products are widely used for the treatment of immunodeficiency disease, ITP, chronic lymphocytic leukemia (CLL), and others. Rise in geriatric population, increase in patient population of blood disorders, and high healthcare expenditure are anticipated to boost the market growth.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/2586

Key Findings of the Immunoglobulin Market:

• Myasthenia Gravis segment is projected to grow at the fastest rate during the analysis period.
• Hypogammaglobulinemia was the highest revenue-generating segment, and is expected to continue its dominance in future.
• North America dominated global immunoglobulins market, and is projected to grow at a CAGR of 7.0% in terms of value.
• Saudi Arabia is expected to grow at the fastest rate in the LAMEA region, registering a CAGR of 11.8%. in terms of value.
• LAMEA segment was the fastest growing segment growing at a CAGR of 10.6% in terms of volume.

Table Of Content

Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. OVERVIEW OF IMMUNOGLOBULIN
3.2.1. Patented products
3.3. EPIDEMIOLOGY AND ECONOMIC BURDEN OF CHRONIC CONDITIONS
3.4. COST OF SIDE EFFECTS OF IMMUNOGLOBULIN TREATMENT
3.5. KEY FINDINGS
3.5.1. Top factors impacting
3.5.2. Top investment pockets
3.6. PORTER’S FIVE FORCES ANALYSIS
3.7. VALUE CHAIN ANALYSIS
3.7.1. Primary activities
3.7.2. Support activities
3.8. MARKET SHARE ANALYSIS, 2016
3.9. PRODUCT SCENARIO IN IMMUNOGLOBULIN MARKET
3.10. GOVERNMENT REGULATIONS AND REIMBURSEMENTS
3.10.1. U.S.
3.10.2. Europe
3.10.2.1. France
3.10.2.2. Germany
3.10.2.3. Italy
3.10.3. China
3.10.4. Japan
3.10.5. India
3.11. INDICATIONS FOR IMMUNOGLOBULIN
3.11.1. U.S. FDA indications
3.11.2. EMA
3.12. COMPONENT ANALYSIS OF IMMUNOGLOBULIN G (IGG)
3.12.1. IgG1
3.12.2. IgG2
3.12.3. IgG3
3.12.4. IgG4
3.13. CLINICAL TRIALS
3.14. MARKET DYNAMICS
3.14.1. Drivers
3.14.1.1. Rise in prevalence of immunodeficiency diseases
3.14.1.2. Increase in adoption of immunoglobulin
3.14.1.3. Increase in incidence of bleeding disorders
3.14.1.4. Surge in geriatric population
3.14.2. Restraints
3.14.2.1. Stringent government regulations
3.14.2.2. High cost of therapy
3.14.3. Opportunities
3.14.3.1. Opportunities in emerging economies
3.14.3.2. Development of cost-effective therapeutics through large-scale production

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/immunoglobulin-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunoglobulin Market With High Potential Growth, Expected Reach A Valuation Of $17,501 Million by 2025 here

News-ID: 1600441 • Views: 357

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Immunoglobulin

Immunoglobulin Market Opportunity Analysis, 2018-2026
Immunoglobulins are critical part of the immune response, which specifically recognize and bind to particular antigens such as bacteria or viruses aiding in their inhibition. Immunoglobulins also called as antibodies are the glycoprotein molecules produced by plasma cells i.e. white blood cells. The antibody immune response is highly complex and very specific. The various immunoglobulin classes and subclasses (isotypes) differ in their biological features, structure, target specificity and distribution. Hence,
Intravenous Immunoglobulin (IVIg) Market Promising Growth Opportunities over 202 …
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from
Immunoglobulin Products Market Forecast 2017-2025 Explored In Latest Research
Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell.  These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen. These are made up of basic structural unit’s
Intravenous Immunoglobulin Market Analysis & Trends 2024
Transparency Market Research estimates that the global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024. In terms of end users, the hospitals segment is presently leading, accounting for a more than 62% of the overall market in 2015. The segment is, however, expected to lose prominence to
Global Subcutaneous Immunoglobulin Market | MarketResearchReports.biz
Latest industry research report on: Global Subcutaneous Immunoglobulin Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Global Subcutaneous Immunoglobulin Market: Overview Primary humoral immunodeficiency or primary immune deficiency diseases (PIDD) is a group of disorders in which the immune system of an individual does not function properly. In PIDD patients, the number of antibodies produced in the body is not sufficient, or the ones produced are